News & Updates

Patients with treatment-refractory gastroesophageal reflux disease (GERD) may find relief from antireflux mucosectomy (ARMS), suggests a study.

Infection is a common complication in gastric cancer stage II/III patients after gastrectomy, a recent study has found. A low prognostic nutritional index score seems to be an important risk factor for such an outcome.

A recent study has demonstrated the importance of gastrointestinal (GI) symptoms as a clinical morbidity and that these symptoms are associated with increasing age, duration of type 1 diabetes (T1D), haemoglobin A1c (HbA1c), and microvascular complications, but not with autoimmune comorbidities including coeliac disease (CD).

Young, premenopausal women with long or irregular menstrual cycles are at an increased risk of both prevalent and incident nonalcoholic fatty liver disease (NAFLD), reveals a study.

Ulcerative colitis patients suffer from higher levels of anxiety and depressive symptoms, a recent study has found. In addition, disease activity seems to be a good predictor of the severity of these symptoms.

Treatment with infliximab does not lead to a general long-term weight gain in patients with inflammatory bowel disease (IBD), claims a study.

SER-109, an investigational oral microbiome therapeutic, achieves superiority over placebo in reducing recurrent Clostridioides difficile infection (CDI) rates, according to updated findings from the phase III ECOSPOR-III trial.